Dr. J. Nathan Hagstrom, MD, MHCM is a pediatric oncologist in Allentown, PA specializing in pediatric hematology/oncology. He graduated from University of Vermont College of Medicine in 1992 and has 32 years of experience. Dr. J. Nathan Hagstrom, MD, MHCM is affiliated with Lehigh Valley Health Network.
1210 S Cedar Crest Boulevard Suite 1000
Allentown, PA 18103
2545 Shoenersville Road 3rd Floor
Bethlehem, PA 18017
Anemia
Anemia is the most common blood disorder. It occurs when the body does not have enough red blood cells to carry oxygen to the tissues. Blood loss, insufficient red blood cell production, and red blood cell destruction are the three main causes of anemia. These issues may arise from such conditions as iron deficiency, heavy periods, ulcers, kidney disease, as well as some forms of cancer.
An individual with anemia will have the following symptoms: shortness of breath, weakness, dizziness, cold hands or feet, paleness, and irritability. Anemia is diagnosed when blood tests show low counts for hemoglobin, which is the protein responsible for carrying oxygen to different tissues throughout the body.
Treatments for anemia are dependent on the kind of anemia an individual has. For example, iron supplementation may correct iron deficiency anemia. For anemia caused by chronic kidney failure, chemotherapy treatments, and HIV/AIDS, a group of medications called erythropoiesis-stimulating agents may be prescribed.
Hemophilia
Hemophilia is a bleeding disorder in which blood cannot clot normally. After an injury, people who have hemophilia bleed longer because they lack certain blood proteins that are responsible for clotting, called clotting factors. Some hemophiliacs are mildly deficient in this protein, so they bleed only when injured or after surgery. Those who are severely deficient, however, may experience symptoms of spontaneous bleeding, including the following:
Most people with hemophilia have a family history of the disorder, though about 30% do not. The most common forms are hemophilia A (classic hemophilia) and hemophilia B (Christmas disease). Hemophilia A and B share certain characteristics, but different genes are involved. Acquired hemophilia is very rare and has been linked to autoimmune conditions, cancer, and multiple sclerosis.
Hemophilia may be diagnosed using a blood test. If there is family history of the disorder, testing may be done prenatally. Treatment involves regular intravenous replacement of clotting factors, which may be produced in a laboratory (recombinant) or come from blood donors. For people with milder forms of the disease, a hormone called desmopressin may stimulate the body to produce clotting factors. Other drug therapies include medications that help slow the breakdown of blood clots and medications that are applied directly to the wound to promote clotting.
Living with hemophilia can be challenging, but simple things may help prevent excessive bleeding. For example, choosing activities like walking or swimming over contact sports can prevent injuries and strengthen muscles while protecting the joints. Chances for bleeding may also be reduced by making sure that children wear helmets and elbow pads during activities like bicycle rides.
Thrombocytosis (High Platelet Count)
Thrombocytosis is a disorder where people have too high of a concentration of platelets. Excess platelets can cause blood to clot in the veins. Blood clots in the veins are particularly dangerous, as they can obstruct blood flow and cause heart attacks and strokes. Thrombocytosis has two forms:
If a doctor suspects a patient has thrombocytosis, a complete blood count (CBC) or platelet count test helps determine the concentration of platelets in a person's blood at a given time. Thrombocytosis can be diagnosed by hematologists using advanced tests on platelet samples. Flow cytometry tests detect abnormalities by evaluating the characteristics of a platelet sample using targeted lasers and lights.
Patients with high platelet counts are frequently prescribed a daily dose of over-the-counter medication aspirin to thin the blood. Platelet-lowering medications, such as hydroxyurea and Intron A, may reduce the likelihood of blood clot formation. Excess platelets may also be removed from the blood by a procedure called plateletpheresis or platelet reduction apheresis, where blood is drawn, circulated into a centrifuge that separates the blood components, and returned to the body with some platelets extracted. Plateletpheresis is a rare procedure reserved for patients who have severe clotting.
Patients can also modify their lifestyle to better manage their disorder and minimize complications. Patients with thrombocytosis are advised to drink plenty of water, exercise regularly, and to avoid smoking. Many people with thrombocytosis live healthy and fulfilling lives with proper treatment and precautions.
Dr. J. Nathan Hagstrom, MD, MHCM graduated from University of Vermont College of Medicine in 1992. He completed residency at The Children's Hospital of Philadelphia. He is certified by the American Board of Pediatrics - Pediatrics and has a state license in Connecticut.
Medical School: University of Vermont College of Medicine (1992)
Residency: The Children's Hospital of Philadelphia (1993)
Board Certification: American Board of Pediatrics - Pediatrics
Licensed In: Connecticut
Dr. J. Nathan Hagstrom, MD, MHCM is associated with these hospitals and organizations:
Dr. J. Nathan Hagstrom, MD, MHCM has an exceptional overall rating with an average of 4.88 out of 5 stars based on 30 ratings. We collect ratings and reviews of Dr. J. Nathan Hagstrom, MD, MHCM from all over the web to help you find the right in Allentown, PA.
These charts describe general payments received by Dr. J. Nathan Hagstrom, MD, MHCM. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Pfizer Inc. |
$10,760
BENEFIX $5,715 |
REFACTO $4,062 |
XYNTHA $983 |
|
---|---|---|---|---|
Biogen Idec Inc. |
$5,300
$5,300 |
|||
Bayer HealthCare Pharmaceuticals Inc. |
$2,225
$2,225 |
|||
CSL Behring |
$245
Hizentra $18 |
$227 |
||
Octapharma USA, Inc. |
$204
Nuwiq $110 |
WILATE $94 |
||
Other |
$90
PROMACTA $34 |
Oncaspar $21 |
Eloctate $18 |
ALPROLIX $17 |
Consulting Fee | $17,294 |
---|---|
Food and Beverage | $810 |
Travel and Lodging | $712 |
Education | $9 |
Dr. J. Nathan Hagstrom, MD, MHCM has received 7 research payments totaling $26.
Dr. J. Hagstrom is a specialist in pediatric hematology/oncology. He works in Bethlehem, PA. Dr. Hagstrom obtained a license to practice in Connecticut.